Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy

Ophthalmology. 2020 Jun;127(6):835-836. doi: 10.1016/j.ophtha.2020.01.017. Epub 2020 Jan 17.

Authors

Robin A Vora¹, Amar P Patel², Ronald Melles²

Affiliations

¹ Kaiser Permanente Northern California, Oakland, California. Electronic address: robin.vora@kp.org.
² Kaiser Permanente Northern California, Oakland, California.

PMID: 32085877
DOI: 10.1016/j.ophtha.2020.01.017

No abstract available

MeSH terms

Administration, Oral
Aged
Aged, 80 and over
Anticoagulants / toxicity*
Cystitis, Interstitial / drug therapy
Drug-Related Side Effects and Adverse Reactions / diagnosis
Drug-Related Side Effects and Adverse Reactions / epidemiology*
Female
Humans
Macular Degeneration / chemically induced*
Macular Degeneration / diagnosis
Macular Degeneration / epidemiology
Male
Middle Aged
Pentosan Sulfuric Polyester / toxicity*
Prevalence
Retina / drug effects*
Retrospective Studies
Tomography, Optical Coherence

Substances

Anticoagulants
Pentosan Sulfuric Polyester